Lifewatch AG (LIFE.S) Quote| Reuters.com
Edition:
United States

Lifewatch AG (LIFE.S)

LIFE.S on Swiss Exchange

12.05CHF
11:30am EDT
Change (% chg)

CHF0.15 (+1.26%)
Prev Close
CHF11.90
Open
CHF12.35
Day's High
CHF12.35
Day's Low
CHF12.05
Volume
5,091
Avg. Vol
18,026
52-wk High
CHF18.00
52-wk Low
CHF10.50

LIFE.S

Chart for LIFE.S

About

Lifewatch AG is a Switzerland-based company that provides healthcare technology and solutions. Based on real-time patient data, the technologies help physicians detect and analyze patient detect and analyze patient symptoms before they turn into health problems. Its product and service portfolio comprises a broad range of... (more)
No analyst recommendations are available for LIFE.S.

Overall

Beta: 0.54
Market Cap(Mil.): CHF160.46
Shares Outstanding(Mil.): 13.48
Dividend: --
Yield (%): --

Financials

  LIFE.S Industry Sector
P/E (TTM): -- 30.94 34.67
EPS (TTM): -0.87 -- --
ROI: -29.55 8.50 14.11
ROE: -38.14 12.83 15.33

BRIEF-Lifewatch turns the page on key legal matters

* Its subsidiary Lifewatch Services, Inc. and Highmark Blue Cross Blue Shield agreed to a compromise on previously announced, international arbitration award related to Lifewatch's practices billing in years 2009-2010

Jun 01 2016

BRIEF-LifeWatch accepts offer from back-stop investor for ordinary capital increase

* Said on Thursday accepted offer from back-stop investor for ordinary capital increase

Apr 15 2016

BRIEF-Lifewatch to adjust 2015 figures for one-off legal decision

* Confirms its 2016 guidance that revenues will continue to grow at above market growth rates

Mar 23 2016

BRIEF-Lifewatch liable for $18.7 mln plus interest in Highmark case

* arbitrator found lifewatch liable for damages in amount of usd 18.7 million, plus interest

Mar 21 2016

BRIEF-Lifewatch announces arbitration decision in Highmark case

* Arbitrator from international centre for dispute resolution issued a material adverse arbitration decision against its subsidiary, Lifewatch Services, Inc. related to its dispute with Highmark blue cross blue shield

Mar 17 2016

BRIEF-Lifewatch FY revenue up 8.3 pct at $106.63 mln

* FY net profit of $1.62 million (2014: net loss $2.73 million)

Mar 17 2016

BRIEF-Lifewatch appoints Andrew Moore as CFO, effective April 1

* Appointment of Andrew Moore as Chief Financial Officer effective April 1, 2016 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 02 2016

BRIEF-Lifewatch receives FDA clearance for its continuous Vital Signs Monitoring Service

* Announces that it has received FDA clearance for its continuous vital signs monitoring service Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 09 2016

BRIEF-LifeWatch FY total revenue up 8.2 pct

* Said on Friday total revenue grew by 8.2 pct in 2015, which is slightly below guidance

Feb 01 2016

BRIEF-LifeWatch to suspend home sleep testing services

* Said on Sunday decided to suspend its current home sleep testing services while it explores new innovations and options for providing more efficient service to customers and patients

Jan 18 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$25.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.